BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hesperos Inc. - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://hesperosinc.com
X-WR-CALDESC:Events for Hesperos Inc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20270314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20271107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260429
DTSTAMP:20260427T211337
CREATED:20260427T163409Z
LAST-MODIFIED:20260427T163409Z
UID:3712-1777248000-1777420799@hesperosinc.com
SUMMARY:Hesperos Presenting at Stanford Drug Discovery Symposium 2026
DESCRIPTION:Hesperos\, Inc. is excited to announce that our Chief Scientist\, James J. Hickman\, Ph.D.\, and Senior Scientist\, Kaveena Autar\, PhD\, are attending the Stanford Drug Discovery Symposium (SDDS 2026). This premier event brings together leading researchers\, industry professionals\, and innovators to discuss the latest breakthroughs and technologies in drug development. \nPoster Presentation: “In Vitro to In Vivo Translatability of Functional Human-on-a-Chip Systems for Digital Twin Modeling” \nKaveena will present Poster #10 that describes how Hesperos’ Human-on-a-Chip® (HoaC) single and multi-organ system platform models bridge the translational gap between preclinical discovery and predicted clinical outcomes to de-risk and accelerate development pipelines in a cost-effective manner. The research describes how integration of the HoaC platform models with advanced\, in silico\, pharmacokinetic/pharmacodynamic (PK/PD) digital twin modeling can better predict clinical dosing strategies from in vitro readouts. The poster showcases two compelling case studies: (1) an assessment of neurocognitive functional rescue using one of our CNS models and\, (2) accurate predictions of clinical dosing regimens using our multi-organ Malaria-on-a-Chip model. \nAbout our Team\nJames J. Hickman\, Ph.D.\, is Co-Founder and Chief Scientist at Hesperos\, Inc. He also is the Founding Director of the NanoScience Technology Center at the University of Central Florida. A pioneer in the MPS field\, Dr. Hickman\, has spent over 30 years developing functional in vitro systems. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE)\, the National Academy of Inventors\, and is the President of the International Microphysiological Systems Society (IMPSS). \nKaveena Autar\, PhD is a Senior Scientist\, her research focuses on the translatability of functional in vitro systems\, with particular emphasis on advanced neuronal studies. She has developed phenotypic models of human induced pluripotent stem cell (hiPSC)-derived cortical neurons to characterize network maturation and disease pathology. \nAttending SDDS 2026? We invite you to connect with J and Kaveena to discuss how Hesperos’ platform technology can support and accelerate your drug development programs in an expedient\, cost-effective manner.\n\nLink to the Full Program
URL:https://hesperosinc.com/event/hesperos-presenting-at-stanford-drug-discovery-symposium-2026/
LOCATION:Frances C. Arrillaga Alumni Center\, 326 Galvez St\, Stanford\, CA\, 94305\, United States
CATEGORIES:Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/04/SDDS2026-Graphic.jpg
END:VEVENT
END:VCALENDAR